| Product Code: ETC7632976 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to see a high concentration of large molecule drug substance CDMO import shipments, with the top exporting countries being the USA, UK, Germany, Metropolitan France, and Serbia. Despite a negative compound annual growth rate (CAGR) of -4.18% from 2020 to 2024 and a steep decline in growth rate from 2023 to 2024 at -30.16%, the market remained competitive with a very high concentration as measured by the Herfindahl-Hirschman Index (HHI). This indicates a steady flow of imports in the sector, with key players maintaining a strong presence in the Irish market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Large Molecule Drug Substance CDMO Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Ireland Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Ireland Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug development services |
4.2.2 Growth in biopharmaceutical research and development activities in Ireland |
4.2.3 Favorable government initiatives and policies supporting the biopharmaceutical industry |
4.3 Market Restraints |
4.3.1 Intense competition from other global CDMOs |
4.3.2 Regulatory challenges and compliance requirements in the biopharmaceutical sector |
5 Ireland Large Molecule Drug Substance CDMO Market Trends |
6 Ireland Large Molecule Drug Substance CDMO Market, By Types |
6.1 Ireland Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Ireland Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Ireland Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Ireland Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Ireland Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Ireland Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of repeat business from existing clients |
8.2 Number of new partnerships and collaborations formed |
8.3 Average project turnaround time for large molecule drug substance development |
9 Ireland Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Ireland Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Ireland Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Ireland Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Ireland Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here